Trending cosmetic procedures following COVID vaccination
Returning and first-time patients alike are getting ready for the post-vaccination era and booking more cosmetic treatments than ever! Our own Dr. Mitalee Christman shares with Allure magazine two of the top treatments that patients are requesting following COVID vaccination.
FRAXEL “is so popular that Dr. Christman calls it one of her ‘big three’ procedures right now, crediting the laser’s ‘predictable, immediate, and gorgeous outcomes’ that promises a look and feel of rejuvenation and vitality.”
THERMAGE for skin tightening is one of Dr. Christman’s go-to recommendations. “The zero-downtime Thermage, […] she says ‘basically lifts and almost shrink-wraps the lower face’ in the right patient.”
A safe neuromodulator that lasts 6 months is dream that’s closer to come true. The approved ones last 3 months.
Results of Revance’s DAXI neurotoxin study on frown lines, forehead lines and crow’s-feet, show evidence of longer lasting results without sacrificing safety, according to our own Dr. Jeffrey Dover who led the phase 2 study at SkinCare Research. Dr. Dover said to Dermatology Times that “Revance neuromodulator produces an impressive effect on lines of negative facial expression and lasts longer than any of the other neuromodulators approved by the FDA thus far.” “The median duration […] was 24 weeks. If approved, [he believes] daxibotulinumtoxinA will change the landscape of neuromodulators significantly.”
Such a long lasting neurotoxin that doesn’t sacrifice safety, remains the holy grail of neuromodulators and will be a definite plus for many of our patients !
Our very own Dr. Jeffrey Dover weighs in on the ASDS guidelines addressing COVID-19 vaccine concerns related to dermal fillers for Dermatology Times.
Below are the takeaways from his quotes:
Inflammation at the site of filler injections following the Moderna COVID-19 vaccination seems to be similar to infrequently-reported reactions after other vaccines, like flu vaccines.
Such filler inflammation can be successfully treated in the unlikely event it occurs. Several reliable treatment options are available to our physicians.
People should get the vaccine as soon as it is available, regardless of their filler history.
For people who have had filler before, watch out for potential swelling in the area filler injections, and notify your dermatologist if you have any problems whatsoever.
For people who are slated to receive the Moderna vaccine, consider getting your filler injections after receiving 2 doses of the vaccine.
In a challenging year for our community, having 9 of our physicians recognized again by their peers in Boston Magazine’s 2021 Top Doctors list is a reassuring constant. Now more than ever, this recognition is a tribute to SkinCare Physicians’ continued commitment to bringing the most comprehensive, safest and highest quality medical, surgical and aesthetic dermatologic care to our patients.
While everything has changed around us, our dedicated doctors and staff remain true to our practice’s core value: being industry leaders in caring for our patients and each other.
Dr. Jeffrey Dover answers the question “Is the Pandemic an Anti-Ager?” for the online magazine Aesthetic Authority. He explains why the majority of his patients are looking better now than they did before the pandemic.
Dr. Arndt on the skin’s barrier function for Harvard Health Publishing
Harvard Health Publishing interviewed SkinCare Physicians’ Dr. Kenneth Arndt on the role of the skin in our body’s defense system. Our physician founder explains how our skin helps to keep harmful organisms and substances from getting inside our body, and how to best take care of it to maintain its barrier function. Learn more in the Harvard Health’s August 2020 article entitled The Body’s overlooked defense system.
Dr. Rohrer on the promising nano-pulse stimulation for skin lesions
Dr. Thomas Rohrer was recently interviewed by DermatologyTimes on the promising nano-pulse stimulation (NPS) application to treat skin lesions, benign ones and possibly malignancies. According to him, “Nano-Pulse Stimulation […] is an exciting new technology that has demonstrated efficacy for clearing various benign cutaneous lesions and holds great interest for its potential application to treat malignancies.” As a dermatologic surgeon specializing in skin cancer and aesthetic dermatology, Dr. Rohrer has a major interest in “the potential for NPS to treat melanoma and stimulate an immune response that can target metastases […]”. Read the full article in the February issue of DermatologyTimes.